Subscribe

Co-Diagnostics, Inc. (CODX)

USD2.49 -0.08 (-3.11%)
US NASDAQ Healthcare Biotechnology
Address 2401 S. Foothill Dr. 84109
Salt Lake City, UT, US
CEO Dwight Egan
Website co-dx.com
IPO 2017-07-12
CIK 1692415 ISIN US1897632048

Explore sections of this company profile

Description

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

News Sentiment (7d)
66 Positive

Based on only 1 article — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD2.49 -0.08 (-3.11%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
2.75
Float Shares
1.04M
Free Float %
93.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-6.98% -25.93% +10.34% -35.74% -85.66% -68.44% -85.27% -96.05% -99.26% -99.08% -99.08%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (5 ratings, all time) Hold
Price Targets & DCF
Current price
2.49
Low 180.00 +7,128.9%
Consensus 180.00 +7,128.9%
Median 180.00 +7,128.9%
High 180.00 +7,128.9%
DCF (Unlevered) 7.42 +197.9%
DCF (Levered) 7.84 +214.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 0% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 2 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month — —
Last Quarter — —
Last Year — —
All Time 3
270.00
+10,743.4%
Quality scores
Altman Z-Score
-7.94
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Biotechnology: +1.6%
    -84.1% Q1'26: +190.3% (vs Q1'25)
  • ✗
    EPS growth Biotechnology: +29.7%
    +5.2% Q1'26: +42.4% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Biotechnology: +16.2%
    -5,209.4% Q1'26: -5,473.2% (vs Q1'25)
  • ✗
    EBIT margin Biotechnology: +0.0%
    -5,025.5% Q1'26: +0.0% (vs Q1'25)
  • ✗
    ROIC Biotechnology: -16.1%
    -313.4% Q1'26: +0.0% (vs Q1'25)
  • ✗
    Share dilution Biotechnology: -3.4%
    +31.6% Q1'26: +110.9% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.04× Q1'26: -0.06× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.26) × ERP
WACC = 63% × Ke + 37% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 7.42 Current price: 2.49
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana. 		Dec 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
39.9K
est: 39.0K (+2.3%)
215.0K
est: 206.0K (+4.4%)
74.55M
est: 72.37M (+3.0%)
97.89M
est: 98.42M (-0.5%)
34.22M
est: 38.32M (-10.7%)
6.81M
est: 9.14M (-25.4%)
3.92M
est: 4.14M (-5.5%)
622.5K
est: 484.7K (+28.4%)
552.4K
551.7K – 553.1K
+14.0% YoY
17.19M
17.16M – 17.21M
+3,011.1% YoY
59.36M
59.36M – 59.36M
+245.4% YoY
136.59M
136.41M – 136.77M
+130.1% YoY
EBITDA
-6.09M
est: -9.9K (-61,530.5%)
-6.02M
est: -52.2K (-11,446.7%)
41.83M
est: -18.32M (+328.3%)
46.40M
est: -24.92M (+286.2%)
-10.31M
est: -9.70M (-6.2%)
-41.48M
est: -5.17M (-702.8%)
-38.70M
est: -2.34M (-1,552.9%)
-30.18M
est: -274.1K (-10,911.2%)
-312.4K
-312.8K – -311.9K
-14.0% YoY
-9.72M
-9.73M – -9.71M
-3,011.2% YoY
-33.57M
-33.57M – -33.57M
-245.4% YoY
-77.23M
-77.34M – -77.13M
-130.1% YoY
EBIT
-6.14M
est: -10.2K (-60,011.4%)
-6.09M
est: -53.9K (-11,191.6%)
41.69M
est: -18.94M (+320.1%)
46.06M
est: -25.76M (+278.8%)
-11.59M
est: -10.03M (-15.6%)
-42.71M
est: -5.24M (-714.8%)
-40.08M
est: -2.38M (-1,587.4%)
-31.28M
est: -278.0K (-11,152.2%)
-316.9K
-317.3K – -316.5K
-14.0% YoY
-9.86M
-9.87M – -9.85M
-3,011.2% YoY
-34.05M
-34.05M – -34.05M
-245.4% YoY
-78.35M
-78.46M – -78.25M
-130.1% YoY
Net Income
-6.27M
est: -14.56M (+56.9%)
-6.20M
est: -10.82M (+42.7%)
42.48M
est: 47.22M (-10.0%)
36.66M
est: 33.29M (+10.1%)
-14.24M
est: 2.73M (-621.5%)
-35.33M
est: -1.68M (-1,999.5%)
-37.64M
est: -48.69M (+22.7%)
-46.90M
est: -27.93M (-67.9%)
-16.16M
-16.19M – -16.13M
+42.1% YoY
-15.96M
-15.99M – -15.94M
+1.2% YoY
-9.18M
-9.19M – -9.16M
+42.5% YoY
8.78M
8.76M – 8.79M
+195.7% YoY
SGA
4.74M
est: 73.6K (+6,335.8%)
4.56M
est: 388.7K (+1,072.8%)
12.94M
est: 136.56M (-90.5%)
24.95M
est: 185.72M (-86.6%)
21.61M
est: 72.31M (-70.1%)
21.14M
est: 50.51M (-58.1%)
20.64M
est: 22.89M (-9.8%)
11.44M
est: 2.68M (+327.0%)
3.05M
3.05M – 3.06M
+14.0% YoY
95.00M
94.87M – 95.12M
+3,011.1% YoY
328.15M
328.15M – 328.15M
+245.4% YoY
755.04M
754.05M – 756.02M
+130.1% YoY
EPS
-15.00
est: -0.48 (-3,025.0%)
-11.09
est: -0.36 (-3,009.3%)
1.59
est: 1.56 (+2.1%)
38.10
est: 1.10 (+3,371.5%)
-13.57
est: 0.09 (-15,177.8%)
-36.00
est: -1.27 (-2,745.5%)
-37.20
est: -36.60 (-1.6%)
-35.25
est: -21.00 (-67.9%)
-12.15
-12.17 – -12.13
+42.1% YoY
-12.00
-12.02 – -11.98
+1.2% YoY
-6.90
-6.91 – -6.89
+42.5% YoY
6.60
6.59 – 6.61
+195.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-12 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-11 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-08 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-07 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-06 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-05 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-04 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-05-01 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-04-30 C+ 2/5 1/5 1/5 1/5 3/5 1/5 5/5
2026-04-29 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-28 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-27 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-24 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-23 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-22 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-21 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-20 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-17 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-16 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-30.12M
OE per share TTM
-25.89
Owner's Yield
-1,415.39%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
9.3%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
32
Total invested
940.1K
Insider transactions (90d)
0
Beneficial owners (>5%)
7
Beneficial owners (>5%)
# Reporting person ⇅ Amount owned ⇅ % of class ⇅ Sole voting ⇅ Shared voting ⇅ Sole dispositive ⇅ Shared dispositive ⇅ Type Citizenship Filing date ⇅ SEC filing
1 America 2030 Capital, LLC. 2.27M 17.60% 2.27M — 2.27M — CO St. Kitts & Nevis 2019-05-09 ↗
2 The Vanguard Group - 23-1945930 1.80M 5.30% — 5.2K 1.78M 13.9K IA Pennsylvania 2022-02-09 ↗
3 2. 1.13M 8.80% 1.13M — 1.13M — CO St. Kitts & Nevis 2019-05-14 ↗
4 (1) BlackRock, Inc. 517.9K 1.80% 517.9K — 517.9K — HC Delaware 2021-07-12 ↗
5 Fifth Third Bancorp. 112.4K 15.27% — 1.38M — 1.38M HC Cayman Islands 2020-01-28 ↗
6 CVI Investments, Inc. — 0.00% — — — — CO Cayman Islands 2020-02-10 ↗
7 Heights Capital Management, Inc. — 0.00% — — — — CO Delaware 2020-02-10 ↗

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2025 Q4
Investors holding
32
-4 vs prev Q
New positions
5
Closed positions
9
Increased
12
Reduced
9
Put/Call ratio
0.14
Calls held
201.5K
Puts held
27.3K
Top institutional holders
# Investor ⇅ Shares / Δ ⇅ Mkt value / Δ ⇅ Own% / Δ ⇅ Weight% / Δ ⇅ Avg px / Perf. ⇅ Hold / Status ⇅
1 VANGUARD GROUP INC 1.91M +203.2K (+11.9%) 322.6K -264.2K (-45.0%) 5.04% -0.114 pp 0.00% +0.000 pp USD8.65 +1,654.2% 33 qtrs —
2 PRIVATE ADVISORY GROUP LLC 1.18M +— (+0.0%) 199.2K -207.3K (-51.0%) 3.12% -0.451 pp 0.02% -0.018 pp USD0.75 +20,132.0% 5 qtrs —
3 RENAISSANCE TECHNOLOGIES LLC 730.3K -137.2K (-15.8%) 123.1K -175.3K (-58.7%) 1.93% -0.693 pp 0.00% 0.000 pp USD4.69 +3,135.4% 19 qtrs —
4 GEODE CAPITAL MANAGEMENT, LLC 449.1K +129.2K (+40.4%) 81.2K -28.9K (-26.3%) 1.19% +0.219 pp 0.00% +0.000 pp USD10.05 +1,409.9% 31 qtrs —
5 BLACKROCK, INC. 427.4K +— (+0.0%) 72.1K -75.0K (-51.0%) 1.13% -0.163 pp 0.00% +0.000 pp USD1.25 +12,039.2% 6 qtrs —
6 BANK OF NEW YORK MELLON CORP 137.1K +— (+0.0%) 23.1K -24.0K (-51.0%) 0.36% -0.052 pp 0.00% +0.000 pp USD11.73 +1,193.6% 24 qtrs —
7 STATE STREET CORP 100.6K +— (+0.0%) 17.0K -17.7K (-51.0%) 0.27% -0.038 pp 0.00% +0.000 pp USD16.60 +814.1% 23 qtrs —
8 KESTRA ADVISORY SERVICES, LLC 88.2K -46.5K (-34.5%) 14.9K -31.5K (-67.9%) 0.23% -0.174 pp 0.00% 0.000 pp USD1.11 +13,570.3% 12 qtrs —
9 NORTHERN TRUST CORP 55.0K +— (+0.0%) 9.3K -9.6K (-51.0%) 0.15% -0.021 pp 0.00% +0.000 pp USD14.84 +922.5% 24 qtrs —
10 SUMMIT FINANCIAL WEALTH ADVISORS, LLC 40.0K +40.0K (+100.0%) 6.7K +6.7K (+100.0%) 0.11% +0.106 pp 0.00% +0.001 pp USD151.74 +0.0% 1 qtrs NEW
11 JANE STREET GROUP, LLC 33.9K +17.1K (+101.8%) 5.7K -63.0 (-1.1%) 0.09% +0.039 pp 0.00% +0.000 pp USD0.34 +44,529.4% 2 qtrs —
12 UBS GROUP AG 31.5K -86.8K (-73.4%) 5.3K -35.4K (-86.9%) 0.08% -0.274 pp 0.00% +0.000 pp USD0.35 +43,254.3% 33 qtrs —
13 TWO SIGMA SECURITIES, LLC 30.8K +30.8K (+100.0%) 5.2K +5.2K (+100.0%) 0.08% +0.081 pp 0.00% +0.001 pp USD151.74 +0.0% 1 qtrs NEW
14 REGAL INVESTMENT ADVISORS LLC 25.0K +9.0K (+56.3%) 4.2K -1.3K (-23.4%) 0.07% +0.018 pp 0.00% 0.000 pp USD0.31 +48,848.4% 4 qtrs —
15 CITADEL ADVISORS LLC 14.1K +14.1K (+100.0%) 2.4K +2.4K (+100.0%) 0.04% +0.037 pp 0.00% +0.000 pp USD151.74 +0.0% 1 qtrs NEW
16 SUSQUEHANNA INTERNATIONAL GROUP, LLP 13.2K -18.6K (-58.5%) 2.2K -8.6K (-79.4%) 0.03% -0.061 pp 0.00% +0.000 pp USD0.34 +44,529.4% 2 qtrs —
17 TOWER RESEARCH CAPITAL LLC (TRC) 13.0K +11.5K (+768.6%) 2.2K +1.7K (+326.0%) 0.03% +0.030 pp 0.00% +0.000 pp USD0.34 +44,529.4% 24 qtrs —
18 SIMPLEX TRADING, LLC 9.7K -9.2K (-48.5%) 1.6K -4.4K (-72.6%) 0.03% -0.032 pp 0.00% +0.000 pp USD0.32 +47,318.8% 9 qtrs —
19 BAADER BANK AKTIENGESELLSCHAFT 10.3K +10.3K (+100.0%) 1.1K +1.1K (+100.0%) 0.03% +0.027 pp 0.00% +0.000 pp USD151.74 +0.0% 1 qtrs NEW
20 SMARTLEAF ASSET MANAGEMENT LLC 4.0K +4.0K (+100.0%) 723.00 +723.0 (+100.0%) 0.01% +0.011 pp 0.00% +0.000 pp USD151.74 +0.0% 1 qtrs NEW
21 GLOBAL RETIREMENT PARTNERS, LLC 3.0K +— (+0.0%) 506.00 -526.0 (-51.0%) 0.01% -0.001 pp 0.00% +0.000 pp USD0.27 +56,100.0% 3 qtrs —
22 WELLS FARGO & COMPANY/MN 2.5K +2.2K (+794.5%) 414.00 +319.0 (+335.8%) 0.01% +0.006 pp 0.00% +0.000 pp USD2.95 +5,043.7% 24 qtrs —
23 MORGAN STANLEY 2.2K -3.6K (-62.0%) 371.00 -1.6K (-81.4%) 0.01% -0.012 pp 0.00% +0.000 pp USD2.92 +5,096.6% 24 qtrs —
24 JPMORGAN CHASE & CO 663.00 -304.0 (-31.4%) 112.00 -220.0 (-66.3%) 0.00% -0.001 pp 0.00% +0.000 pp USD0.27 +56,100.0% 11 qtrs —
25 BANK OF AMERICA CORP /DE/ 504.00 +183.0 (+57.0%) 85.00 -25.0 (-22.7%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.13 +13,328.3% 9 qtrs —
26 ADVISOR GROUP HOLDINGS, INC. 300.00 -1.6K (-84.5%) 51.00 -581.0 (-91.9%) 0.00% -0.005 pp 0.00% +0.000 pp USD0.60 +25,190.0% 24 qtrs —
27 NEWEDGE ADVISORS, LLC 200.00 +— (+0.0%) 34.00 -35.0 (-50.7%) 0.00% 0.000 pp 0.00% +0.000 pp USD2.40 +6,222.5% 13 qtrs —
28 — 78.00 +78.0 (+100.0%) 13.00 +13.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD151.54 +0.1% 1 qtrs NEW
29 BNP PARIBAS ARBITRAGE, SNC 60.00 +— (+0.0%) 10.00 -11.0 (-52.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.50 +10,016.0% 23 qtrs —
30 HRT FINANCIAL LP — -149.3K (-100.0%) — -51.0K (-100.0%) 0.00% -0.451 pp 0.00% 0.000 pp USD— 4 qtrs SOLD
31 HERITAGE WEALTH ADVISORS — -525.0 (-100.0%) — -181.0 (-100.0%) 0.00% -0.002 pp 0.00% +0.000 pp USD— 24 qtrs SOLD
32 GROUP ONE TRADING, L.P. — -54.3K (-100.0%) — -18.7K (-100.0%) 0.00% -0.164 pp 0.00% +0.000 pp USD— 10 qtrs SOLD
33 SMI ADVISORY SERVICES, LLC — -28.0K (-100.0%) — -10.8K (-100.0%) 0.00% -0.085 pp 0.00% -0.002 pp USD— 9 qtrs SOLD
34 ENVESTNET ASSET MANAGEMENT INC — -30.8K (-100.0%) — -10.6K (-100.0%) 0.00% -0.093 pp 0.00% +0.000 pp USD— 4 qtrs SOLD
35 CITIGROUP INC — -1.5K (-100.0%) — -501.0 (-100.0%) 0.00% -0.004 pp 0.00% +0.000 pp USD— 4 qtrs SOLD
36 VIRTU FINANCIAL LLC — -126.5K (-100.0%) — -44.0K (-100.0%) 0.00% -0.382 pp 0.00% -0.003 pp USD— 7 qtrs SOLD
37 GROUND SWELL CAPITAL, LLC — -11.5K (-100.0%) — -4.0K (-100.0%) 0.00% -0.035 pp 0.00% -0.009 pp USD— 2 qtrs SOLD
38 SBI SECURITIES CO., LTD. — -1.4K (-100.0%) — -481.0 (-100.0%) 0.00% -0.004 pp 0.00% +0.000 pp USD— 5 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.70
Neutral
Ratio by volume
0.84
Neutral
Buys
7
Sells
10
Shares acquired
584.2K
Shares disposed
691.7K
Cash buys
—
Cash sales
—
Net activity
-107,498
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2025-11-23 SERBIN RICHARD S Director M-Exempt D Restricted Stock Unit 57,499 0.00 — 170,834 D ↗
2025-11-23 NELSON JAMES B Director M-Exempt D Restricted Stock Unit 57,499 0.00 — 170,834 D ↗
2025-11-23 Murphy Edward L. Director A-Award A Common Stock 57,499 0.00 — 281,666 D ↗
2025-11-23 Egan Dwight H Director / Officer A-Award A Common Stock 163,333 0.00 — 797,827 D ↗
2025-11-23 Durenard Eugene Director M-Exempt D Restricted Stock Unit 57,499 0.00 — 170,834 D ↗
2025-11-23 Brown Brian Lee Officer M-Exempt D Restricted Stock Unit 134,167 0.00 — 337,500 D ↗
2025-11-23 Abbott Richard David Officer D-Return D Common Stock 17,200 0.35 6.0K 66,202 D ↗
2025-08-13 SERBIN RICHARD S Director A-Award A Restricted Stock Units 125,000 0.00 — 228,333 D ↗
2025-08-13 NELSON JAMES B Director A-Award A Restricted Stock Units 125,000 0.00 — 228,333 D ↗
2025-08-13 MURPHY TED Director A-Award A Restricted Stock Units 125,000 0.00 — 228,333 D ↗
2025-08-13 Egan Dwight H Director / Officer A-Award A Restricted Stock Units 275,000 0.00 — 575,833 D ↗
2025-08-13 Durenard Eugene Director A-Award A Restricted Stock Units 125,000 0.00 — 228,333 D ↗
2025-08-13 Brown Brian Lee Officer A-Award A Restricted Stock Units 225,000 0.00 — 471,667 D ↗
2025-08-13 Abbott Richard David Officer A-Award A Restricted Stock Units 220,000 0.00 — 350,438 D ↗
2025-05-23 SERBIN RICHARD S Director M-Exempt D Restricted Stock Unit 48,334 0.00 — 103,333 D ↗
2025-05-23 NELSON JAMES B Director M-Exempt D Restricted Stock Unit 48,334 0.00 — 103,333 D ↗
2025-05-23 MURPHY TED Director M-Exempt D Restricted Stock Unit 48,334 0.00 — 103,333 D ↗
2025-05-23 Egan Dwight H Director / Officer M-Exempt D Restricted Stock Unit 163,334 0.00 — 300,833 D ↗
2025-05-23 Durenard Eugene Director M-Exempt D Restricted Stock Unit 48,334 0.00 — 103,333 D ↗
2025-05-23 Brown Brian Lee Officer M-Exempt D Restricted Stock Unit 134,166 0.00 — 246,667 D ↗
2025-05-23 Abbott Richard David Officer D-Return D Common Stock 7,180 0.24 1.7K 26,735 D ↗
2024-11-23 SERBIN RICHARD S Director M-Exempt D Restricted Stock Unit 48,333 0.00 — 151,667 D ↗
2024-11-23 NELSON JAMES B Director M-Exempt D Restricted Stock Unit 48,333 0.00 — 151,667 D ↗
2024-11-23 MURPHY TED Director A-Award A Common Stock 48,333 0.00 — 175,833 D ↗
2024-11-23 Egan Dwight H Director / Officer D-Return D Common Stock 49,689 1.01 50.2K 522,858 D ↗
2024-11-23 Durenard Eugene Director M-Exempt D Restricted Stock Unit 48,333 0.00 — 151,667 D ↗
2024-11-23 Brown Brian Lee Officer M-Exempt D Restricted Stock Unit 134,167 0.00 — 380,833 D ↗
2024-11-23 Abbott Richard David Officer D-Return D Common Stock 6,085 1.01 6.1K 13,915 D ↗
2024-05-23 SERBIN RICHARD S Director M-Exempt D Restricted Stock Unit 30,000 0.00 — 200,000 — ↗
2024-05-23 NELSON JAMES B Director M-Exempt D Restricted Stock Unit 30,000 0.00 — 200,000 — ↗
2024-05-23 MURPHY TED Director M-Exempt D Restricted Stock Unit 30,000 0.00 — 200,000 — ↗
2024-05-23 Egan Dwight H Director / Officer D-Return D Common Stock 42,008 1.09 45.8K 367,206 — ↗
2024-05-23 Durenard Eugene Director M-Exempt D Restricted Stock Unit 30,000 0.00 — 200,000 — ↗
2024-05-23 Brown Brian Lee Officer D-Return D Common Stock 35,865 1.09 39.1K 290,689 — ↗
2024-04-26 SERBIN RICHARD S Director A-Award A Restricted Stock Units 110,000 0.00 — 230,000 — ↗
2024-04-26 NELSON JAMES B Director A-Award A Restricted Stock Units 110,000 0.00 — 230,000 — ↗
2024-04-26 MURPHY TED Director A-Award A Restricted Stock Units 110,000 0.00 — 230,000 — ↗
2024-04-26 Egan Dwight H Director / Officer A-Award A Restricted Stock Units 275,000 0.00 — 765,833 — ↗
2024-04-26 Durenard Eugene Director A-Award A Restricted Stock Units 110,000 0.00 — 230,000 — ↗
2024-04-26 Brown Brian Lee Officer A-Award A Restricted Stock Units 225,000 0.00 — 628,334 — ↗
2024-04-26 Abbott Richard David Officer A-Award A Restricted Stock Units 120,000 0.00 — 170,438 — ↗
2024-03-15 Abbott Richard David Officer — I Common Stock 0 0.00 — 590,816 — ↗
2023-11-23 SERBIN RICHARD S Director A-Award A Common Stock 30,000 0.00 — 87,500 — ↗
2023-11-23 NELSON JAMES B Director A-Award A Common Stock 30,000 0.00 — 85,000 — ↗
2023-11-23 MURPHY TED Director A-Award A Common Stock 30,000 0.00 — 97,500 — ↗
2023-11-23 Egan Dwight H Director / Officer D-Return D Common Stock 46,047 1.26 58.0K 270,881 — ↗
2023-11-23 Durenard Eugene Director A-Award A Common Stock 30,000 0.00 — 85,000 — ↗
2023-11-23 Brown Brian Lee Officer D-Return D Common Stock 36,125 1.26 45.5K 213,220 — ↗
2023-06-12 SERBIN RICHARD S Director A-Award A Restricted Stock Units 70,000 0.00 — 150,000 — ↗
2023-06-12 NELSON JAMES B Director A-Award A Restricted Stock Units 70,000 0.00 — 150,000 — ↗
2023-06-12 MURPHY TED Director A-Award A Restricted Stock Units 70,000 0.00 — 150,000 — ↗
2023-06-12 Durenard Eugene Director A-Award A Restricted Stock Units 70,000 0.00 — 150,000 — ↗
2023-05-23 SERBIN RICHARD S Director A-Award A Common Stock 18,333 0.00 — 57,500 — ↗
2023-05-23 NELSON JAMES B Director M-Exempt D Restricted Stock Units 18,333 0.00 — 80,000 — ↗
2023-05-23 MURPHY TED Director A-Award A Common Stock 18,333 0.00 — 67,500 — ↗
2023-05-23 Egan Dwight H Director / Officer A-Award A Common Stock 105,000 0.00 — 198,197 — ↗
2023-05-23 Durenard Eugene Director A-Award A Common Stock 18,333 0.00 — 55,000 — ↗
2023-05-23 Brown Brian Lee Officer A-Award A Common Stock 80,834 0.00 — 157,070 — ↗
2023-05-15 Egan Dwight H Director / Officer A-Award A Restricted Stock Unit 275,000 0.00 — 746,667 — ↗
2023-05-15 Brown Brian Lee Officer A-Award A Restricted Stock Units 225,000 0.00 — 602,500 — ↗
2023-03-20 Brown Brian Lee Officer P-Purchase A Common Stock 3,000 1.90 5.7K 76,236 — ↗
2023-01-17 SERBIN RICHARD S Director A-Award A Restricted Stock Units 40,000 0.00 — 98,333 — ↗
2023-01-17 NELSON JAMES B Director A-Award A Restricted Stock Units 40,000 0.00 — 98,333 — ↗
2023-01-17 MURPHY TED Director A-Award A Restricted Stock Units 40,000 0.00 — 98,333 — ↗
2023-01-17 Egan Dwight H Director / Officer A-Award A Restricted Stock Units 155,000 0.00 — 471,667 — ↗
2023-01-17 Durenard Eugene Director A-Award A Restricted Stock Units 40,000 0.00 — 98,333 — ↗
2023-01-17 Brown Brian Lee Director / Officer A-Award A Restricted Stock Units 130,000 0.00 — 377,500 — ↗
2023-01-08 SERBIN RICHARD S Director A-Award A Common Stock 12,500 0.00 — 39,167 — ↗
2023-01-08 NELSON JAMES B Director A-Award A Common Stock 12,500 0.00 — 36,667 — ↗
2023-01-08 MURPHY TED Director A-Award A Common Stock 12,500 0.00 — 49,167 — ↗
2023-01-08 Durenard Eugene Director A-Award A Common Stock 12,500 0.00 — 36,667 — ↗
2022-11-23 SERBIN RICHARD S Director M-Exempt D Restricted Stock Units 11,667 0.00 — 70,833 — ↗
2022-11-23 NELSON JAMES B Director M-Exempt D Restricted Stock Units 11,667 0.00 — 70,833 — ↗
2022-11-23 MURPHY TED Director M-Exempt D Restricted Stock Units 11,667 0.00 — 70,833 — ↗
2022-11-23 Egan Dwight H Director / Officer M-Exempt D Restricted Stock Units 79,166 0.00 — 316,667 — ↗
2022-11-23 Durenard Eugene Director A-Award A Common Stock 11,667 0.00 — 24,167 — ↗
2022-11-23 Brown Brian Lee Director / Officer M-Exempt D Restricted Stock Units 59,167 0.00 — 247,500 — ↗
2022-07-11 SERBIN RICHARD S Director A-Award A Restricted Stock Units 70,000 0.00 — 82,500 — ↗
2022-07-11 NELSON JAMES B Director A-Award A Restricted Stock Units 70,000 0.00 — 82,500 — ↗
2022-07-11 MURPHY TED Director A-Award A Restricted Stock Units 70,000 0.00 — 82,500 — ↗
2022-07-11 Durenard Eugene Director A-Award A Restricted Stock Units 70,000 0.00 — 82,500 — ↗
2022-06-06 Egan Dwight H Director / Officer A-Award A Restricted Stock Units 275,000 0.00 — 395,833 — ↗
2022-06-06 Brown Brian Lee Director / Officer A-Award A Restricted Stock Units 225,000 0.00 — 306,667 — ↗
2022-05-23 Egan Dwight H Director / Officer D-Return D Common Stock 11,854 4.99 59.2K 46,141 — ↗
2022-05-23 Brown Brian Lee Director / Officer D-Return D Common Stock 7,869 4.99 39.3K 32,256 — ↗
2022-01-08 SERBIN RICHARD S Director M-Exempt D Restricted Stock Units 12,500 0.00 — 12,500 — ↗
2022-01-08 NELSON JAMES B Director M-Exempt D Restricted Stock Units 12,500 0.00 — 12,500 — ↗
2022-01-08 MURPHY TED Director M-Exempt D Restricted Stock Units 12,500 0.00 — 12,500 — ↗
2022-01-08 Durenard Eugene Director A-Award A Common Stock 12,500 0.00 — 12,500 — ↗
2021-11-23 Egan Dwight H Director / Officer F-InKind D Common Stock 15,544 8.44 131.2K 24,661 — ↗
2021-11-23 Brown Brian Lee Officer A-Award A Common Stock 21,667 0.00 — 25,143 — ↗
2021-09-08 Durenard Eugene Director S-Sale D Common Stock 2,000 10.46 20.9K 0 — ↗
2021-08-12 Egan Dwight H Director / Officer A-Award A Restricted Stock Units 125,000 0.00 — 187,500 — ↗
2021-08-12 Brown Brian Lee Officer A-Award A Restricted Stock Units 100,000 0.00 — 125,000 — ↗
2021-05-24 Egan Dwight H Director / Officer M-Exempt D Restricted Stock Units 12,500 0.00 — 62,500 — ↗
2021-05-24 Brown Brian Lee Officer F-InKind D Common Stock 1,524 7.90 12.0K 3,476 — ↗
2021-05-24 BENSON REED L Officer F-InKind D Common Stock 1,414 7.90 11.2K 3,170 — ↗
2021-05-19 BENSON REED L Officer M-Exempt D Stock Option (Right to Buy) 10,920 2.63 28.7K 0 — ↗
2021-02-23 Satterfield Brent Officer — — — 0 0.00 — 0 — ↗
2021-02-22 Brown Brian Lee Officer A-Award A Restricted Stock Units 30,000 0.00 — 30,000 — ↗
2021-01-15 Egan Dwight H Director / Officer M-Exempt A Common Stock 50,000 2.63 131.5K 50,000 — ↗
2021-01-14 SERBIN RICHARD S Director S-Sale D Common Stock 10,000 10.29 102.9K 2,500 — ↗
2021-01-13 NELSON JAMES B Director S-Sale D Common Stock 11,900 10.13 120.5K 600 — ↗
2021-01-13 Durenard Eugene Director S-Sale D Common Stock 10,500 10.09 105.9K 2,000 — ↗
2021-01-07 SERBIN RICHARD S Director A-Award A Restricted Stock Units 37,500 0.00 — 37,500 — ↗
2021-01-07 NELSON JAMES B Director A-Award A Restricted Stock Units 37,500 0.00 — 37,500 — ↗
2021-01-07 Murphy Edward L. Director A-Award A Restricted Stock Units 37,500 0.00 — 37,500 — ↗
2021-01-07 Durenard Eugene Director A-Award A Restricted Stock Units 37,500 0.00 — 37,500 — ↗
2020-12-14 SERBIN RICHARD S Director S-Sale D Common Stock 17,000 10.10 171.7K 0 — ↗
2020-12-10 Durenard Eugene Director S-Sale D Common Stock 10,000 10.15 101.5K 0 — ↗
2020-11-25 BENSON REED L Officer M-Exempt A Common Stock 100,000 1.10 110.0K 100,000 — ↗
2020-11-24 Egan Dwight H Director / Officer F-InKind D Common Stock 5,236 1.10 5.8K 44,764 — ↗
2020-11-23 SERBIN RICHARD S Director M-Exempt D Restricted Stock Units 17,000 0.00 — 0 — ↗
2020-11-23 Egan Dwight H Director / Officer S-Sale D Common Stock 71,569 10.44 747.2K 0 — ↗
2020-11-23 Durenard Eugene Director M-Exempt D Restricted Stock Units 10,000 0.00 — 0 — ↗
2020-11-23 BENSON REED L Officer A-Award A Restricted Stock Units 27,500 0.00 — 27,500 — ↗
2020-11-20 Egan Dwight H Director / Officer S-Sale D Common Stock 18,017 11.09 199.8K 0 — ↗
2020-05-28 SERBIN RICHARD S Director M-Exempt A Common Stock 25,000 3.96 99.0K 25,000 — ↗
2020-05-26 Durenard Eugene Director S-Sale D Common Stock 25,000 18.24 456.0K 0 — ↗
2020-05-20 Durenard Eugene Director M-Exempt A Common Stock 25,000 0.71 17.8K 25,000 — ↗
2020-05-19 SERBIN RICHARD S Director M-Exempt A Common Stock 25,000 0.71 17.8K 25,000 — ↗
2020-04-01 Reagents, LLC — J-Other D Common Stock 25,000 192,505.00 4.81B 1,746,796 — ↗
2020-02-10 SERBIN RICHARD S Director A-Award A Non-Qualified Stock Option (right to buy) 25,000 3.96 99.0K 25,000 — ↗
2020-02-10 Durenard Eugene Director A-Award A Non-Qualified Stock Option (right to buy) 25,000 3.96 99.0K 25,000 — ↗
2019-09-03 NELSON JAMES B Director — D Non-Qualified Stock Option (right to buy) 25,000 1.10 27.5K 0 — ↗
2019-09-03 Egan Dwight H Director / Officer A-Award A Non-Qualified Stock Option (right to buy) 150,000 1.10 165.0K 150,000 — ↗
2019-09-03 BENSON REED L Officer A-Award A Non-Qualified Stock Option (right to buy) 125,000 1.10 137.5K 125,000 — ↗
2019-06-25 Durenard Eugene Director A-Award A Non-Qualified Stock Option (right to buy) 25,000 0.71 17.8K 25,000 — ↗
2019-04-24 SERBIN RICHARD S Director A-Award A Non-Qualified Stock Option (right to buy) 25,000 0.71 17.8K 25,000 — ↗
2019-04-24 Murphy Edward L. Director — D Non-Qualified Stock Option (right to buy) 25,000 0.71 17.8K 0 — ↗
2018-12-06 America 2030 Capital, LLC 10% Owner D-Return D COMMON STOCK 1,134,898 0.01 11.3K 0 — ↗
2018-10-05 Egan Dwight H Director / Officer A-Award A Non-Qualified Stock Option (right to buy) 150,000 2.75 412.5K 150,000 — ↗
2018-10-05 BENSON REED L Officer A-Award A Non-Qualified Stock Option (right to buy) 125,000 2.75 343.8K 125,000 — ↗
2018-07-18 America 2030 Capital, LLC 10% Owner D-Return D COMMON STOCK 1,134,897 0.01 11.3K 1,134,898 — ↗
2018-05-11 Satterfield Brent Director / Officer / 10% Owner P-Purchase A Common Stock 1,305 1.82 2.4K 2,275,000 — ↗
2018-05-03 Satterfield Brent Director / Officer / 10% Owner P-Purchase A Common Stock 500 1.91 955.00 2,273,695 — ↗
2018-04-27 America 2030 Capital, LLC 10% Owner — D COMMON STOCK 0 0.00 — 2,269,795 — ↗
2018-04-23 Satterfield Brent Director / Officer / 10% Owner P-Purchase A Common Stock 500 2.02 1.0K 2,273,198 — ↗
2018-04-16 Satterfield Brent Director / Officer / 10% Owner P-Purchase A Common Stock 500 1.94 970.00 2,272,698 — ↗
2018-04-09 Satterfield Brent Director / Officer / 10% Owner P-Purchase A Common Stock 2,400 2.05 4.9K 2,272,198 — ↗
2017-12-13 BENSON REED L Officer D-Return D Common Stock 17,792 4.65 82.7K 0 — ↗
2017-09-19 Reagents, LLC — J-Other D Common Stock 181,817 0.00 — 1,771,796 — ↗
2017-08-08 SERBIN RICHARD S Director — D Stock Options 36,250 3.85 139.6K 0 — ↗
2017-08-08 Kiesner Frank J Director — D Stock Options 36,250 3.85 139.6K 0 — ↗
2017-08-08 BORKOWSKI EDWARD Director — D Stock Options 36,250 3.85 139.6K 0 — ↗
2017-07-11 Satterfield Brent Director / Officer — D Common Stock 0 0.00 — 2,269,798 — ↗
2017-07-11 Reagents, LLC 10% Owner — D Common Stock 0 0.00 — 1,953,613 — ↗
2017-07-11 Legends Capital Group, LLC 10% Owner — D Common Stock 0 0.00 — 1,300,344 — ↗
2017-07-11 Egan Dwight H — — — — 0 0.00 — 0 — ↗
2017-07-11 BENSON REED L Officer — I Common Stock 0 0.00 — 20,568 — ↗
2015-11-12 Legends Capital Group, LLC 10% Owner — D Warrant 4,545 6.00 27.3K 0 — ↗

Executive team

Top executives
EBIT / Employee
-2.8K
Shares Outstanding
1.12M

Executive compensation

Executive compensation (annual)
# Year ⇅ Executive ⇅ Salary ⇅ Bonus Stock award ⇅ Option award Incentive Other Total ⇅ % Stock-
based ⇅		 Filing
1 2024 Dwight Egan President Chief Executive Officer 391.7K 20.0K 305.3K — — — 716.9K 42.58% ↗
2 2024 Brian Brown Chief Financial Officer and Secretary 313.3K 15.0K 249.8K — — — 578.1K 43.20% ↗
3 2024 Richard Abbott President 276.7K 15.0K 133.2K — — — 424.9K 31.35% ↗
4 2023 Dwight Egan, Chief Executive Officer 375.0K 40.8K 845.6K — — — 1.26M 67.04% ↗
5 2023 Brian Brown, Chief Financial Officer and Secretary 306.9K 32.0K 701.6K — — — 1.04M 67.43% ↗
6 2022 Dwight Egan President Chief Executive Officer 366.1K 146.2K 1.45M — — — 1.97M 73.95% ↗
7 2022 Brian Brown Chief Financial Officer and Secretary 280.9K 106.6K 1.19M — — — 1.58M 75.44% ↗
8 2021 Dwight Egan President Chief Executive Officer 350.0K 638.5K 1.21M — — 26.8K 2.22M 54.35% ↗
9 2021 Dwight Egan President Chief Executive Officer 350.0K 638.5K 1.21M — — 26.8K 2.22M 54.35% ↗
10 2021 Brian Brown Chief Financial Officer and Secretary 209.7K 475.0K 1.44M — — 26.8K 2.15M 66.95% ↗
11 2021 Brian Brown Chief Financial Officer and Secretary 209.7K 475.0K 1.44M — — 26.8K 2.15M 66.95% ↗
12 2021 Reed Benson Former Chief Financial Officer and Secretary 136.3K 154.7K — — — 26.8K 317.7K 0.00% ↗
13 2020 Dwight H. Egan President Chief Executive Officer 309.4K 350.0K — — — 17.5K 1.46M 0.00% ↗
14 2020 Dwight Egan President Chief Executive Officer 309.4K 350.0K 786.8K — — 17.5K 1.46M 53.75% ↗
15 2020 Reed L Benson Chief Financial Officer and Secretary Brent Satterfield 211.5K 225.0K — — — 17.5K 742.4K 0.00% ↗
16 2020 Reed Benson Former Chief Financial Officer and Secretary 211.5K 225.0K 288.5K — — 17.5K 742.4K 38.86% ↗
17 2019 Reed L Benson Chief Financial Officer and Secretary Brent Satterfield 200.0K 15.0K — — — — 742.4K 0.00% ↗
18 2019 Dwight H. Egan President Chief Executive Officer 275.0K 20.0K — — — — 460.0K 0.00% ↗
19 2019 Reed L Benson Chief Financial Officer and Secretary 200.0K 15.0K — — — — 352.5K 0.00% ↗
20 2019 Brent Satterfield Chief Technology Officer 237.5K — — — — — 237.5K 0.00% ↗
21 2018 Dwight H. Egan President Chief Executive Officer 275.0K 12.5K — — — — 463.5K 0.00% ↗
22 2018 Reed L Benson Chief Financial Officer and Secretary 200.0K 10.0K — — — — 365.0K 0.00% ↗
23 2018 Brent Satterfield Chief Technology Officer 237.5K — — — — — 237.5K 0.00% ↗
24 2018 Brent Satterfield Chief Science Officer 237.5K — — — — — 237.5K 0.00% ↗
25 2017 Dwight H. Egan President Chief Executive Officer 195.0K 15.0K — — — — 210.0K 0.00% ↗
26 2017 Reed L Benson Chief Financial Officer and Secretary 195.0K 10.0K — — — — 205.0K 0.00% ↗
27 2017 Brent Satterfield Chief Technology Officer 159.3K — — — — — 159.3K 0.00% ↗
28 2017 Brent Satterfield Chief Science Officer 159.3K — — — — — 159.3K 0.00% ↗
29 2016 Brent Satterfield Chief Science Officer 81.1K — — — — — 81.1K 0.00% ↗
30 2016 Brent Satterfield Chief Technology Officer 81.1K — — — — — 81.1K 0.00% ↗
31 2016 Dwight H. Egan President Chief Executive Officer 23.8K — — — — — 23.8K 0.00% ↗
32 2016 Reed L Benson Chief Financial Officer and Secretary — — — — — — — — ↗
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-11-10 DEF 14A ↗
2025-10-31 PRE 14A ↗
2025-04-14 DEF 14A ↗
2024-07-16 DEF 14A ↗

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-12 S-3 ↗
2026-03-31 8-K ↗
2026-03-31 10-K ↗
2026-03-10 8-K ↗
2026-02-11 SC 13G/A ↗
2026-01-21 S-8 ↗
2026-01-13 8-K ↗
2025-12-30 8-K ↗
2025-12-19 424B5 ↗
2025-12-05 8-K ↗

Executive team

NameTitleCompensationGender
Dwight H. Egan Chairman, CEO & President 460.0K male
Brian L. Brown Chief Financial Officer & Company Secretary 365.0K male
Richard David Abbott President 305.0K male
David Nielsen Chief Operating Officer — male
Mayuranki Almaula Senior Vice President of Overseas Operations & Strategic Alliances — —
Andrew Benson Head of Investor Relations — male
Seth Egan Chief Commercialization Officer — male
Christopher Thurston Chief Technology Officer — male
Dan Bohrer Vice President of Finance & Accounting — male
ESG Rating
B
MEDICAL - DEVICES
Rank: 102 out of 168
2025
E (Environmental)
54.3 / 62.5
Company / Sector avg.
S (Social)
60.8 / 68.9
Company / Sector avg.
G (Governance)
62.6 / 64.8
Company / Sector avg.
ESG Total
59.3 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Biotechnology